Week In Review: China And The US May Settle De-Listing/Accounting Impasse
August 27, 2022 at 15:20 PM EDT
China and the US are close to solving the accounting rules crisis that threatens to de-list 261 China companies from US exchanges. The list of affected biopharma companies includes BeiGene, Legend Bio, Zai Labs, and many more.
